Healthcare >> CEO Interviews >> April 15, 2005

Michael Weiner – Biophan Technologies (biph)

MICHAEL L. WEINER - CEO of Biophan Technologies began his career at Xerox Corporation in 1975, where he served in a variety of capacities in sales and marketing, including manager of software market expansion and manager of sales compensation planning. In 1982, he received the President's Award, the top honor at Xerox for an invention benefiting a major product line. In 1985, Weiner founded Microlytics, a Xerox spin- off company which developed technology from the Xerox Palo Alto Research Center into a suite of products, including the award winning Word Finder thesaurus, with licenses out to over 150 companies, including Apple, Microsoft, and Sony. Microlytics was acquired by a merger with a public company in 1990, which Weiner then headed up through 1993. In January, 1993 Weiner co-founded TextWise, a company developing natural language search technologies for the intelligence community. In 1995, Weiner co- founded and served as CEO of Manning & Napier Information Services searches, and other services, for the U.S. Patent and Trademark Office and many large corporations, and which subsequently acquired TextWise. He held this position until January of 1999. MNIS remains private, and has generated several spin-off companies (Talavara and IP.COM). TextWise won the Department of Commerce Tibbet's Award for SBIR research in 1998. In February, 1999, Weiner founded Technology Innovations, LLC, to develop intellectual property assets. In August, 2000, Technology Innovations created a subsidiary, Biomed Solutions, LLC, to pursue biomedical and nanotechnology opportunities, investing in embryonic-to- seed stage innovations which generate new ventures and/or licenses. These companies are holding companies for intellectual property assets and equities in other ventures. Weiner has been CEO of Biophan Technologies, Inc. since co-founding the company in December, 2000, with Wilson Greatbatch, P.E., the inventor of the first successful implantable cardiac pacemaker, which Greatbatch licensed to Medtronic in 1960. Biophan's primary mission is to develop and commercially exploit technologies for providing competitive advantage to biomedical device companies, including technology for enabling biomedical devices to be safe and compatible with MRI diagnostics. Biophan spun out of Biomed Solutions in December, 2000, through a merger with a public company, trading under the symbol BIPH. Biophan recently acquired a majority interest in TE-Bio, LLC, which is developing with NASA a patented biothermal battery for powering implantable devices based on thermal deltas in body heat, taking advantage of advances in nanomaterials. Weiner serves on the Boards of Biophan, Biomed Solutions, LLC, Technology Innovations, LLC, Speech Compression Technologies, LP, Nanoset, LLC, MYOTECH, LLC, TE-Bio, LLC, and OncoVista, Inc. These companies, all founded or co-founded by Weiner, hold over 200 patents pending, issued, allowed, and/or licensed in (Biophan alone currently has 114). Weiner has been a member of the Licensing Executives Society (LES) since 1984, and is a member of IEEE, AAAS, AFIO, and the NY Inventor's Club. Weiner believes that society can benefit by improving the methods by which innovation moves from idea to application and commercialization. Profile
TWST: Begin, if you will, with a brief historical sketch of the company

and a picture of the things you are doing at the present time.

Mr. Weiner: At the end of 2000, our goal was to make